Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Gilead Sciences, Inc. Transaction History

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD

$385 Million
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$72.34 - $84.0 $757,833 - $879,984	-10,476 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $655,064 - $733,843	10,476 New	10,476 $681,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $634,217 - $827,604	-10,476 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $343,003 - $418,159	4,709 Added 81.65%	10,476 $773,000
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $410,322 - $481,659	5,767	5,767 $413,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD, based on Form 13F filings with the SEC.

News

Stay updated on Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD with notifications on news.

Account